Key Finding
Macrophage-derived extracellular vesicles function as polarization-dependent information carriers, with M1 EVs delivering tumor-suppressive signals and M2 EVs promoting tumor progression, immune suppression, and therapy resistance across multiple cancer types.
This laboratory study examined how immune cells called macrophages release tiny packages called extracellular vesicles (EVs) that can either help fight cancer or help it grow, depending on the macrophage's activation state. Researchers reviewed how M1 macrophages (tumor-fighting) release EVs containing molecules that slow cancer growth, stop cancer spread, and boost the immune system's ability to attack tumors. In contrast, M2 macrophages (tumor-promoting) release EVs that help cancer cells survive, resist treatment, avoid the immune system, and spread to other parts of the body. This is a review of existing research rather than a new patient study, so it doesn't directly involve acupuncture treatment. However, understanding how the immune system communicates in the tumor environment is important background knowledge. For patients considering cancer treatment, this research suggests future possibilities for engineered therapies that could boost anti-tumor immune responses or block cancer-promoting signals. While this basic science research doesn't provide immediate treatment options, it may eventually lead to new supportive therapies that could complement conventional cancer care. Acupuncture practitioners working with cancer patients focus on symptom management and quality of life during treatment. If you're considering acupuncture for cancer-related symptoms, seek a licensed acupuncturist with specialized training in oncology support care.
This comprehensive review examines polarization-dependent molecular cargo in macrophage-derived extracellular vesicles (EVs) and their role in tumor microenvironment modulation. M1 macrophage-derived EVs carry tumor-suppressive cargo including noncoding RNAs and immunomodulatory proteins that inhibit proliferation, invasion, immune evasion, and therapeutic resistance. M2-derived EVs deliver pro-tumorigenic signals promoting epithelial-mesenchymal transition, metabolic reprogramming, stemness, ferroptosis resistance, and immunosuppression. The review synthesizes mechanisms of polarization-dependent cargo selection, including RNA-binding protein-mediated sorting and metabolic pathway control. No original patient data, sample sizes, or effect sizes are reported as this is a mechanistic review of existing literature. Clinical relevance centers on translational potential: M1 EVs represent engineering platforms for enhancing anti-tumor responses, while M2 EVs are therapeutic targets for disruption. This foundational immunology research has no direct acupuncture application but informs understanding of immune modulation in oncology contexts.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.